| 3 |
ビーログ 血液凝固異常症レジストリePRO
Accelight Inc.
|
|
2025-02-21 |
- |
0
|
385
|
0
|
0 |
No |
*This app is an app for entering medication records for those who participate in the Blood Coagulati |
Detail
♡
|
| 2 |
PRO-DUCE研究
Accelight Inc.
|
|
2021-01-29 |
- |
0
|
76
|
0
|
0 |
No |
It is intended only for those who participate in the "Randomized Controlled Trial Examining the Usef |
Detail
♡
|
| 1 |
STSJMOG-ePRO
Accelight Inc.
|
|
2023-02-16 |
- |
0
|
29
|
0
|
0 |
No |
Only those who participate in the "Monitoring study using ePRO in patients undergoing chemotherapy f |
Detail
♡
|
| 6 |
J-CAT ePRO
Accelight Inc.
|
|
2022-03-17 |
- |
0
|
7
|
0
|
0 |
No |
This application is only for those who participate in "". |
Detail
♡
|
| 9 |
MAPLE-Study
Accelight Inc.
|
|
2025-08-14 |
- |
0
|
6
|
0
|
0 |
No |
*This app is a communication support app for participants in the MAPLE Study. |
Detail
♡
|
| 8 |
Good Morning, Habataki
Accelight Inc.
|
|
- |
- |
0
|
2
|
0
|
0 |
No |
A wellbeing check-in app for registered users of the Habataki Foundation. |
Detail
♡
|
| 4 |
STSSOOS-ePRO
Accelight Inc.
|
|
- |
- |
0
|
1
|
0
|
0 |
No |
It is intended only for those who participate in the "ePRO Survey Compliance Study in Patients with |
Detail
♡
|
| 5 |
|
|
- |
- |
0
|
0
|
0
|
0 |
No |
『2次化学療法実施中の切除不能膵癌患者におけるePROを 用いたQOL調査研究』にご参加いただく方のみを対象としています。 |
Detail
♡
|
| 7 |
|
|
- |
- |
0
|
0
|
0
|
0 |
No |
乳がんの薬物療法は、抗腫瘍効果により病気の治る確率を高めたり、病気の進行を遅らせるなどの恩恵を期待し実施されますが、同時に様々な副作用を伴います。 |
Detail
♡
|
